Fhmls X, L.P. bought $10.0M of MBX Biosciences (MBX)

Executed Sep 16 2024, disclosed Sep 17 2024, 1 day later.

Value, as filed

$10.0M

625,000 sh × $16.00

Executed

Sep 16 2024

the trade date, as filed

Disclosed

Sep 17 2024

1 day after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

+9.6%

-1.9% from execution

Over the 21 trading sessions from the disclosed entry session (Sep 17 2024), the stock returned +9.6% (delay-adjusted); from the execution session (Sep 16 2024), -1.9%. Derived: entry at the session's open, exit at the close 20 sessions later.

The filer

FP Fhmls X, L.P. 10% owner profile →

Paydirt holds 0 Form 4 reports by Fhmls X, L.P. from the past 24 months (0 purchases, 0 sales); returns are computed at the next nightly build.

The name

MBX MBX MBX · 8 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→